Marshall Wace, LLP Veru Inc. Transaction History

Marshall Wace, LLP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$4.35 - $15.85 $220,858 - $804,736	50,772 Added 65.44%	128,353 $1.45 Million
Q1 2022 May 16, 2022	BUY	$4.55 - $6.41 $352,993 - $497,294	77,581 New	77,581 $375,000
Q4 2021 Feb 14, 2022	SELL	$5.89 - $9.73 $1.03 Million - $1.7 Million	-174,744 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$6.78 - $9.89 $1.18 Million - $1.73 Million	174,744 New	174,744 $1.49 Million
Q2 2021 Aug 13, 2021	SELL	$7.24 - $11.2 $1.01 Million - $1.57 Million	-139,993 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$8.05 - $20.78 $1.13 Million - $2.91 Million	139,993 New	139,993 $1.51 Million

123

56.9M

668K

531K

Ticker VERU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,146,704
Market Cap $56.9M
Description
Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.